Plain-English translation of NCT07188064 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical procedure called the PRP-NR procedure that uses a nerve graft to help restore erectile function in men who have experienced erectile dysfunction after prostate cancer surgery. The surgery involves taking a nerve from your groin area and connecting it to nerves in the penis to help restore the ability to have erections. Researchers will track how well this treatment works and monitor for any side effects over a two-year period.
Many men experience erectile dysfunction after prostate cancer surgery, and current treatment options don't work for everyone. This trial exists to see if this new nerve grafting technique can offer a solution for men whose erectile function hasn't returned on its own.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo the nerve grafting surgery at the hospital. After surgery, you'll have follow-up visits at 4 weeks and then at 3, 6, 12, 18, and 24 months. At each visit, you'll complete questionnaires about your erectile function and sexual health, and the research team will check for any complications from the surgery.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Canada
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre, Western University, Canada
Enrollment target
~100 participants
Started
January 2026
Primary completion
November 2028
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Victor McPherson, MD
Sir Mortimer B. Davis - Jewish General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.